PDLIM2 expression is downregulated in steatohepatitis, and experimental evidence has demonstrated that deletion of the PDLIM2 gene promotes hepatic dyslipidemia and exacerbates insulin resistance in mice. Here, PDLIM2 is linked to Insulin resistance.